| Bioactivity | Elenestinib (BLU-263) is a potent and orally active tyrosine kinase inhibitor. Elenestinib has the potential for the research of systemic mastocytosis (SM)[1]. | |||||||||
| Name | Elenestinib | |||||||||
| CAS | 2505078-08-8 | |||||||||
| Formula | C27H29FN10O | |||||||||
| Molar Mass | 528.58 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Mariana Castells, et al. A Phase 2/3 Study of BLU-263 in Patients with Indolent Systemic Mastocytosis or Monoclonal Mast Cell Activation Syndrome. Allergy and Clinical Immunology. 2022, 149 (2). |
Elenestinib
CAS: 2505078-08-8 F: C27H29FN10O W: 528.58
Elenestinib (BLU-263) is a potent and orally active tyrosine kinase inhibitor. Elenestinib has the potential for the res
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.